Literature DB >> 7359324

Tissue distribution of antitumor drugs associated with polyalkylcyanoacrylate nanoparticles.

P Couvreur, B Kante, V Lenaerts, V Scailteur, M Roland, P Speiser.   

Abstract

Polymethylcyanoacrylate nanoparticles, polyethylcyanoacrylate nanoparticles, and free 3H-dactinomycin and 3H-vinblastine were studied with emphasis on their distribution pattern in rat tissues after intravenous administration. The adsorption of cytostatic drugs to polyalkylcyanoacrylate nanoparticles can modify drug distribution in tissues. Particularly with vinblastine, modification of drug disposition is important. Data are given concerning the formation and stability of nanoparticle--drug complexes. Polyalkylcyanoacrylate nanoparticles seem to be an interesting drug carrier owing to their size, structure, degradability, and drug sorptive properties.

Entities:  

Mesh:

Substances:

Year:  1980        PMID: 7359324     DOI: 10.1002/jps.2600690222

Source DB:  PubMed          Journal:  J Pharm Sci        ISSN: 0022-3549            Impact factor:   3.534


  12 in total

1.  Paclitaxel-loaded poly(n-butylcyanoacrylate) nanoparticle delivery system to overcome multidrug resistance in ovarian cancer.

Authors:  Fei Ren; Ruda Chen; Ying Wang; Yabin Sun; Yaodong Jiang; Guofeng Li
Journal:  Pharm Res       Date:  2010-12-24       Impact factor: 4.200

Review 2.  Polymeric materials for theranostic applications.

Authors:  Zhe Wang; Gang Niu; Xiaoyuan Chen
Journal:  Pharm Res       Date:  2013-06-14       Impact factor: 4.200

3.  Preparation and in vivo studies of a new drug delivery system. Nanoparticles of alkylcyanoacrylate.

Authors:  P Maincent; J P Devissaguet; R LeVerge; P A Sado; P Couvreur
Journal:  Appl Biochem Biotechnol       Date:  1984       Impact factor: 2.926

4.  Biodegradable nanospheres containing phthalocyanines and naphthalocyanines for targeted photodynamic tumor therapy.

Authors:  A Labib; V Lenaerts; F Chouinard; J C Leroux; R Ouellet; J E van Lier
Journal:  Pharm Res       Date:  1991-08       Impact factor: 4.200

Review 5.  The smart targeting of nanoparticles.

Authors:  Adam D Friedman; Sarah E Claypool; Rihe Liu
Journal:  Curr Pharm Des       Date:  2013       Impact factor: 3.116

6.  Study on in vivo distribution of liver-targeting nanoparticles encapsulating thymidine kinase gene (TK gene) in mice.

Authors:  Qin He; Wen Min Yuan; Ji Liu; Zhi Rong Zhang
Journal:  J Mater Sci Mater Med       Date:  2007-07-10       Impact factor: 3.896

7.  MRI after magnetic drug targeting in patients with advanced solid malignant tumors.

Authors:  A-J Lemke; M-I Senfft von Pilsach; A Lübbe; C Bergemann; H Riess; R Felix
Journal:  Eur Radiol       Date:  2004-08-05       Impact factor: 5.315

8.  Designing Paclitaxel drug delivery systems aimed at improved patient outcomes: current status and challenges.

Authors:  Madhu S Surapaneni; Sudip K Das; Nandita G Das
Journal:  ISRN Pharmacol       Date:  2012-08-12

Review 9.  Biodegradable nanoparticles are excellent vehicle for site directed in-vivo delivery of drugs and vaccines.

Authors:  Anil Mahapatro; Dinesh K Singh
Journal:  J Nanobiotechnology       Date:  2011-11-28       Impact factor: 10.435

10.  Enhanced in vivo activity of adriamycin incorporated into controlled release microspheres.

Authors:  C Jones; M A Burton; B N Gray
Journal:  Br J Cancer       Date:  1989-05       Impact factor: 7.640

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.